儿童狼疮中发现PACSIN1基因新发变异及PACSIN1/TRAF4复合物在Toll样受体7激活中的作用
研究在一名SLE患儿中发现PACSIN1 Q59K新发错义变异,通过CRISPR/Cas9将其引入人浆细胞样树突状细胞系和小鼠,发现该变异增强TLR-7而非TLR-9信号,导致IFNβ及干扰素诱导基因表达升高;机制上Q59K减弱PACSIN1与TRAF4结合,解除TRAF4对TRAF6介导的I型干扰素激活的抑制。
要点
- PACSIN1 Q59K变异在人细胞中增强TLR-7信号并升高IFNβ和干扰素诱导基因表达。
- Q59K减弱PACSIN1与TRAF4结合,导致TRAF6介导的I型干扰素激活失控。
- 未经治疗的SLE患者外周血PACSIN1表达高,且与干扰素相关基因正相关。
核心结论
- PACSIN1 Q59K通过损害TRAF4对TLR-7信号的抑制来增加IFNβ活性,可能 contributes to SLE风险。
研究设计与样本
- 将PACSIN1 Q59K新发变异和无义变异通过CRISPR/Cas9编辑引入人浆细胞样树突状细胞系和小鼠。
- 采用实时聚合酶链反应和流式细胞术评估变异对人及小鼠细胞TLR-7/TLR-9信号、PACSIN1信使RNA和SLE患者干扰素特征的影响。
- 采用荧光素酶报告基因试验、RNA干扰、免疫共沉淀和免疫荧光研究机制。
主要发现
- PACSIN1与肿瘤坏死因子受体相关因子4(TRAF4)和TRAF6形成三分子复合物,对I型干扰素调节重要。
- PACSIN1 Q59K增强与神经Wiskott-Aldrich综合征蛋白的结合,同时减弱与TRAF4的结合,导致TRAF6介导的I型干扰素激活失控。
- PACSIN1 Q59K在人细胞中增强TLR-7而非TLR-9信号,导致IFNβ和干扰素诱导基因表达升高。
- 未经治疗的SLE患者外周血细胞PACSIN1表达高,且与干扰素相关基因正相关。
- 将Pacsin1 Q59K突变引入小鼠导致B细胞表面TLR-7和TRAIL表达增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increased Toll-like receptor 7 (TLR-7) signaling leading to the production of type I interferon (IFN) is an important contributor to human systemic lupus erythematosus (SLE). Protein kinase C and casein kinase substrate in neurons 1 (PACSIN1), a molecule that regulates synaptic vesicle recycling, has been linked to TLR-7/TLR-9-mediated type I IFN production in humans and mice, but the underlying mechanism is unknown. We undertook this study to explore the pathogenicity and underlying mechanism of a de novo PACSIN1 missense variant identified in a child with SLE. METHODS: PACSIN1 Q59K de novo and null variants were introduced into a human plasmacytoid dendritic cell line and into mice using CRISPR/Cas9 editing. The effects of the variants on TLR-7/TLR-9 signaling in human and mouse cells, as well as PACSIN1 messenger RNA and IFN signature in SLE patients, were assessed using real-time polymerase chain reaction and flow cytometry. Mechanisms were investigated using luciferase reporter assays, RNA interference, coimmunoprecipitation, and immunofluorescence. RESULTS: We established that PACSIN1 forms a trimolecular complex with tumor necrosis factor receptor-associated factor 4 (TRAF4) and TRAF6 that is important for the regulation of type I IFN. The Q59K mutation in PACSIN1 augments binding to neural Wiskott-Aldrich syndrome protein while it decreases binding to TRAF4, leading to unrestrained TRAF6-mediated activation of type I IFN. Intriguingly, PACSIN1 Q59K increased TLR-7 but not TLR-9 signaling in human cells, leading to elevated expression of IFNβ and IFN-inducible genes. Untreated SLE patients had high PACSIN1 expression in peripheral blood cells that correlated positively with IFN-related genes. Introduction of the Pacsin1 Q59K mutation into mice caused increased surface TLR-7 and TRAIL expression in B cells. CONCLUSION: PACSIN1 Q59K increases IFNβ activity through the impairment of TRAF4-mediated inhibition of TLR-7 signaling, possibly contributing to SLE risk.
引用
- Xie C, Zhou H, Athanasopoulos V, et al. De Novo PACSIN1 Gene Variant Found in Childhood Lupus and a Role for PACSIN1/TRAF4 Complex in Toll-like Receptor 7 Activation. Arthritis Rheumatol. 2023. PMID: 36622335. doi:10.1002/art.42416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。